Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus remifentanil for postoperative pain control after radical cystectomy
IRCT20231113060037N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Dexmedetomidine group with Remifentanil group (2 arms). Primary endpoints: Postoperative pain intensity based on VAS score and Postoperative opioid consumption. Started Mar 2026; status: completed.
02
Drugs
dexmedetomidineremifentanil
Beyond the preview
Go deeper on IRCT20231113060037N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231113060037N1.